NEWS AND EVENTS

NEWS

Placeholder1

NICE : Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus: telavancin

Article 1 Image

Clinigen and Theravance Announce Exclusive Commercialization Agreement in the EU for VIBATIV® (telavancin)

Press Release image1

Clinigen Group Reports Pan European Lifting of Marketing Authorization Suspension for VIBATIV® (telavancin)